NEW YORK – Insightful Science said Monday that it has reached an agreement to acquire Dotmatics for an undisclosed amount.
The deal is expected to close during the second quarter. The firms said the combined entity would have "well over" $100 million in annual recurring revenue.
San Diego-based Insightful Science said it will integrate its bioinformatics applications with Dotmatics' enterprise data management technology to create a comprehensive scientific research platform to improve laboratory efficiency. Dotmatics, based in Bishop's Stortford, UK, with an office in San Diego, specializes in software-as-a-service technology to automate lab data workflows.
"We will bring Insightful Science's leading biologics applications to our customers, further accelerating their discovery processes," Dotmatics Cofounder and CEO Steve Gallagher said in a statement. "In addition, we have the opportunity to bring the Dotmatics cloud and collaboration capabilities to the diverse community of over 1 million scientists already using Insightful Science tools."
Insightful Science CEO Thomas Swalla said the business combination will accelerate scientific innovation. "Together, our complementary businesses create an end-to-end, cloud-first scientific research platform that stands apart in our collective ability to support data-driven research," he said.
Evercore served as Insightful's financial advisor and Willkie Farr & Gallagher as its legal advisor on the transaction. Jefferies International was an advisor to Dotmatics.
This is Insightful Science's second bioinformatics acquisition in less than a year. In May, the firm purchased Cytapex, a bioinformatics CRO that partners with pharmaceutical, biotechnology, and medical device companies to improve and automate high-throughput and high-dimensional cytometry informatics for basic and clinical research, biomarker discovery, and clinical trials.
Insightful provides a variety of data analysis and bioinformatics applications for the life sciences, including the Geneious DNA data analysis solution and SnapGene.